Evaluating the Cost-effectiveness of Doacs in Treatment Plans
Direct Oral Anticoagulants (DOACs) have revolutionized the management of thromboembolic disorders. Their ease of use and reduced need for monitoring have made them a preferred choice in many treatment plans. However, their higher drug costs compared to traditional anticoagulants raise questions about their overall cost-effectiveness. Understanding DOACs and Traditional Anticoagulants Traditional anticoagulants like warfarin have … Read more